title: Lipoproteins modify the macrophage uptake of triacylglycerol emulsion and of zymosan particles by similar mechanisms.
abstract: The uptake of lipids and formation of foam cells are key events in atherosclerosis and in eruptive xanthomata formation in primary hyperchylomicronemia. Here we have compared the influence of low density lipoprotein (LDL), oxidized LDL (oxLDL), high density lipoprotein (HDL), and delipidated HDL (apoHDL) on the uptake by macrophages of zymosan (an insoluble fraction of yeast cell walls) and of triglyceride-rich emulsion (EM) particles that resemble chylomicrons, but, like zymosan, are equally devoid of protein components. Zymosan internalization is known to occur through unspecific phagocytosis, whereas natural chylomicrons are taken up by several specific lipoprotein receptors. We found that phagocytosis is not promoted as much by oxLDL as by normal LDL. HDL-coated zymosan was found to be inert and apoHDL slightly enhanced phagocytosis. LDL and apoHDL promoted the uptake of EM while oxLDL and HDL significantly inhibited the uptake. Therefore, the data support that HDL, and not apoHDL, particles inhibit EM uptake. We concluded that by using lipoprotein-coated zymosan particles, we could demonstrate different biological effects of LDL, oxLDL, HDL, and apoHDL on macrophage phagocytosis and that this method could be useful to delineate components of the various lipoproteins important for the propagation or inhibition of the formation of foam cells.
authors.affiliation: Lipids Laboratory, University of São Paulo Medical School, Brazil.
authors.forename: M D
authors.initials: MD
authors.lastname: Carvalho
authors.forename: V E
authors.initials: VE
authors.lastname: Tobias
authors.forename: C M
authors.initials: CM
authors.lastname: Vendrame
authors.forename: A F
authors.initials: AF
authors.lastname: Shimabukuro
authors.forename: M
authors.initials: M
authors.lastname: Gidlund
authors.forename: E C
authors.initials: EC
authors.lastname: Quintão
mesh_terms: D000818:Animals; D004655:Emulsions; D006801:Humans; D008074:Lipoproteins / Q000494:pharmacology*; D008075:Lipoproteins, HDL / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D010587:Phagocytosis; D014280:Triglycerides / Q000378:metabolism*; D015054:Zymosan / Q000378:metabolism*
chemical_list: D004655:Emulsions; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; D015054:Zymosan